PRADIGASTAT

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C25H24F3N3O2
Molecular Weight	455.4722
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of PRADIGASTAT

Structure Search

SMILES

OC(=O)C[C@H]1CC[C@@H](CC1)C2=CC=C(C=C2)C3=CC=C(NC4=CC=C(N=C4)C(F)(F)F)C=N3

InChI

InChIKey=GXALXAKNHIROPE-QAQDUYKDSA-N

InChI=1S/C25H24F3N3O2/c26-25(27,28)23-12-10-21(15-30-23)31-20-9-11-22(29-14-20)19-7-5-18(6-8-19)17-3-1-16(2-4-17)13-24(32)33/h5-12,14-17,31H,1-4,13H2,(H,32,33)/t16-,17-

HIDE SMILES / InChI

Molecular Formula	C25H24F3N3O2
Molecular Weight	455.4722
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 00:14:08 UTC 2023` Edited by `admin` on `Sat Dec 16 00:14:08 UTC 2023`
Record UNII	2U23G6VNUZ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PRADIGASTAT

Official Name

English

LCQ-908-NXA

Code

English

LCQ-908NXA

Code

English

LCQ-908

Common Name

English

LCQ908-NXA

Code

English

LCQ908 - DGAT-1-INHIBITOR

Common Name

English

pradigastat [INN]

Common Name

English

PRADIGASTAT [USAN]

Common Name

English

CYCLOHEXANEACETIC ACID, 4-(4-(5-((6-(TRIFLUOROMETHYL)-3-PYRIDINYL)AMINO)-2-PYRIDINYL)PHENYL)-, TRANS-

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

335711

Created by admin on Sat Dec 16 00:14:08 UTC 2023 , Edited by admin on Sat Dec 16 00:14:08 UTC 2023

Code System Code Type Description

ChEMBL

CHEMBL2364624

Created by admin on Sat Dec 16 00:14:08 UTC 2023 , Edited by admin on Sat Dec 16 00:14:08 UTC 2023

PRIMARY

CAS

956136-95-1

Created by admin on Sat Dec 16 00:14:08 UTC 2023 , Edited by admin on Sat Dec 16 00:14:08 UTC 2023

PRIMARY

SMS_ID

100000183196

Created by admin on Sat Dec 16 00:14:08 UTC 2023 , Edited by admin on Sat Dec 16 00:14:08 UTC 2023

PRIMARY

NCI_THESAURUS

C166592

Created by admin on Sat Dec 16 00:14:08 UTC 2023 , Edited by admin on Sat Dec 16 00:14:08 UTC 2023

PRIMARY

EPA CompTox

DTXSID401026085

Created by admin on Sat Dec 16 00:14:08 UTC 2023 , Edited by admin on Sat Dec 16 00:14:08 UTC 2023

PRIMARY

FDA UNII

2U23G6VNUZ

Created by admin on Sat Dec 16 00:14:08 UTC 2023 , Edited by admin on Sat Dec 16 00:14:08 UTC 2023

PRIMARY

DRUG BANK

DB12866

Created by admin on Sat Dec 16 00:14:08 UTC 2023 , Edited by admin on Sat Dec 16 00:14:08 UTC 2023

PRIMARY

INN

9544

Created by admin on Sat Dec 16 00:14:08 UTC 2023 , Edited by admin on Sat Dec 16 00:14:08 UTC 2023

PRIMARY

EVMPD

SUB197600

Created by admin on Sat Dec 16 00:14:08 UTC 2023 , Edited by admin on Sat Dec 16 00:14:08 UTC 2023

PRIMARY

PUBCHEM

53387035

Created by admin on Sat Dec 16 00:14:08 UTC 2023 , Edited by admin on Sat Dec 16 00:14:08 UTC 2023

PRIMARY

USAN

AB-08

Created by admin on Sat Dec 16 00:14:08 UTC 2023 , Edited by admin on Sat Dec 16 00:14:08 UTC 2023

PRIMARY

Related Record Type Details


					X0EWE8TT2H

PRADIGASTAT SODIUM

SALT/SOLVATE -> PARENT


					0M77ZW789J

URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 2B7

METABOLIC ENZYME -> SUBSTRATE


					0RFO7VC96N

URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A1

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MAJOR


					F0JSU2174Y

DIACYLGLYCEROL O-ACYLTRANSFERASE 1

TARGET -> INHIBITOR

Related Record Type Details


					2U23G6VNUZ

ACTIVE MOIETY